-
Recent Posts
Recent Comments
Archives
Categories
- AAPL
- AFCE
- AFFY
- AGNC
- AMD
- AMZN
- APP
- APPL
- ARNA
- ASPS
- BAC
- BIDU
- BKS
- blog
- bonds
- BP
- C
- CAH
- CECO
- CFNL
- CLWR
- COF
- COH
- CSCO
- DDD
- EBAY
- ED
- EDU
- ELOQ
- equity
- exchange
- FB
- finance
- FSLR
- GDOT
- GMCR
- GMED
- GRPN
- HCA
- HCSG
- HPQ
- IDCC
- ideas
- INTC
- Investing
- Investment
- IPG
- JEF
- JPM
- LGF
- LMT
- M
- MET
- MRVL
- news
- NFLX
- NOK
- ONVO
- OVTI
- P
- PCAR
- PCYC
- PG
- POL
- PWR
- QIHU
- QQQ
- RIMM
- S
- SINA
- SIRI
- SKYW
- SPY
- SSYS
- stock exchange
- stocks
- technology
- technology analysis
- TIVO
- TLAB
- top stories
- trading
- Uncategorized
- UNG
- UVXY
- wall street
- WFC
- WFS
- WMT
- writers
- XOM
- XRTX
- YELF
- YOKU
- ZNGA
Meta
Category Archives: GMED
Sept 18: 2 raising IPOs with unlimited potential: GMED, ELOQ
Eloqua Inc. (NASDAQ: ELOQ) As you may know, I really like using bband. This stock, once again, follow bband trends very nicely. After today correction (considering the body of today’s candlestick is inside yesterday’s one), I wish to see some consolidation on the stock. Any breakout above the all time high would be a good entry of the stock.
Globus Medical (NYSE: GMED) has got its first pre-market approval (PMA) from FDA. The stock grow 7.6% with huge volume. MACD seems to be turning around. Price is touching upper bband. RSI back to overbought level thou. However, it does not mean the stock will drop in the short future. From Vivus (VVUS) and once-popular Arena Pharmaceutical (ARNA), after medical companies get their preliminary approval, the stocks usually run for a while, then drop after final FDA approval. I hope to see GMED would perform in a similar way.
